Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Revenue Breakdown and Options Chain

Gain deeper insights into company revenues with a detailed analysis of revenue sources.
Explore the updated Options feature, providing in-depth data, and a 3D viewing option.

Last Close
Mar 01 04:00PM ET
Dollar change
Percentage change
Index- P/E- EPS (ttm)-4.04 Insider Own24.72% Shs Outstand25.27M Perf Week2.52%
Market Cap329.02M Forward P/E- EPS next Y-3.05 Insider Trans-0.32% Shs Float19.02M Perf Month10.81%
Income-76.81M PEG- EPS next Q-0.61 Inst Own48.48% Short Float3.84% Perf Quarter103.44%
Sales0.00M P/S- EPS this Y31.05% Inst Trans- Short Ratio6.07 Perf Half Y30.46%
Book/sh3.29 P/B3.95 EPS next Y2.86% ROA-53.48% Short Interest0.73M Perf Year119.19%
Cash/sh6.62 P/C1.97 EPS next 5Y1.74% ROE-91.87% 52W Range4.20 - 15.18 Perf YTD59.95%
Dividend Est.- P/FCF- EPS past 5Y26.40% ROI-50.43% 52W High-14.23% Beta0.49
Dividend TTM- Quick Ratio7.33 Sales past 5Y-56.33% Gross Margin- 52W Low210.00% ATR (14)0.92
Dividend Ex-Date- Current Ratio7.33 EPS Y/Y TTM13.80% Oper. Margin0.00% RSI (14)58.81 Volatility7.31% 8.09%
Employees57 Debt/Eq0.47 Sales Y/Y TTM-100.00% Profit Margin- Recom1.00 Target Price27.92
Option/ShortYes / Yes LT Debt/Eq0.46 EPS Q/Q32.19% Payout- Rel Volume2.32 Prev Close12.46
Sales Surprise-100.00% EPS Surprise11.02% Sales Q/Q- EarningsNov 08 AMC Avg Volume120.45K Price13.02
SMA203.39% SMA5019.60% SMA20043.08% Trades Volume279,827 Change4.49%
Date Action Analyst Rating Change Price Target Change
Nov-21-23Resumed BTIG Research Buy $27
Sep-27-23Initiated B. Riley Securities Buy $21
Jun-15-23Upgrade Mizuho Neutral → Buy $24 → $36
Sep-07-22Resumed Alliance Global Partners Buy $6
Apr-29-22Resumed Cantor Fitzgerald Overweight $6 → $5
Apr-14-22Initiated RBC Capital Mkts Outperform $5
Mar-09-22Initiated Truist Buy $6
Jul-01-21Initiated Alliance Global Partners Buy $6
May-24-21Upgrade BTIG Research Neutral → Buy $8
Jun-20-19Downgrade BTIG Research Buy → Neutral
Feb-15-24 03:12AM
Feb-07-24 05:02PM
Jan-29-24 07:00AM
Jan-22-24 08:15AM
04:00PM Loading…
Jan-18-24 04:00PM
Jan-11-24 07:00AM
Jan-05-24 07:00AM
Dec-18-23 07:00AM
Dec-13-23 09:08AM
Dec-03-23 04:17PM
Nov-22-23 12:00PM
Nov-13-23 07:00AM
Nov-08-23 05:52PM
04:12PM Loading…
Nov-07-23 07:00AM
Nov-06-23 07:00AM
Oct-26-23 04:05PM
Oct-18-23 04:50PM
Oct-14-23 12:30PM
Oct-06-23 07:00AM
Sep-28-23 02:15PM
Sep-05-23 07:00AM
Sep-04-23 01:23PM
Aug-28-23 07:00AM
Aug-08-23 05:46PM
Jul-11-23 07:00AM
Jul-10-23 04:05PM
04:05PM Loading…
Jul-05-23 04:05PM
Jun-16-23 05:00AM
Jun-15-23 04:06PM
May-31-23 09:11AM
May-25-23 05:05PM
May-16-23 07:00AM
May-09-23 04:56PM
May-02-23 07:45AM
May-01-23 07:00AM
Apr-26-23 04:05PM
Apr-18-23 07:05AM
Apr-06-23 05:39PM
Mar-15-23 07:00AM
Mar-14-23 04:05PM
Feb-02-23 07:00AM
Jan-30-23 12:00PM
Jan-24-23 05:46PM
Jan-18-23 04:05PM
Jan-11-23 06:24AM
Dec-15-22 04:30PM
Nov-08-22 08:22AM
Nov-03-22 04:05PM
Oct-20-22 07:00AM
Oct-07-22 04:05PM
Oct-04-22 07:00AM
Sep-19-22 09:31AM
Aug-23-22 12:23PM
Aug-08-22 07:00AM
Jul-27-22 11:40AM
Jul-07-22 07:00AM
Jun-27-22 11:17AM
Jun-07-22 02:26PM
Jun-06-22 07:00AM
May-19-22 06:00PM
May-18-22 08:45AM
May-09-22 04:05PM
Apr-04-22 04:05PM
Mar-28-22 01:46PM
Mar-24-22 07:05AM
Mar-01-22 07:52AM
Feb-22-22 05:00AM
Feb-03-22 05:38PM
Jan-11-22 07:00AM
Jan-07-22 07:00AM
Jan-04-22 04:05PM
Nov-23-21 08:53AM
Nov-22-21 07:30AM
Nov-15-21 06:01AM
Nov-14-21 08:53AM
Nov-11-21 07:00AM
Nov-04-21 04:05PM
Oct-26-21 07:00AM
Oct-25-21 04:01PM
Oct-20-21 10:52AM
Sep-27-21 10:08AM
Sep-24-21 04:05PM
Sep-22-21 07:00AM
Sep-20-21 03:49PM
Sep-19-21 11:30AM
Sep-10-21 12:54PM
Verastem, Inc. is a biopharmaceutical company, which engages in the development and commercialization of drugs for the treatment of cancer. The company was founded by Richard H. Aldrich, Michelle Dipp, Piyush Gupta, Satish Jindal, Eric S. Lander, Robert F. Weinberg, and Christoph H. Westphal on August 4, 2010 and is headquartered in Needham, MA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Gagnon Robert E.DirectorFeb 06Sale13.709,204126,09527,804Feb 07 04:00 PM
Gagnon Robert E.DirectorJan 12Sale10.959,204100,78437,008Jan 17 04:00 PM
Calkins DanielChief Financial OfficerJan 05Sale8.506518,621Jan 09 04:03 PM
Calkins DanielChief Financial OfficerDec 26Sale8.08252028,350Dec 28 04:04 PM
Calkins DanielChief Financial OfficerDec 20Sale7.93574528,375Dec 21 04:01 PM
Stuglik Brian MDirectorDec 19Sale7.732742,11890,450Dec 20 04:00 PM
Paterson DanPresident and CEODec 19Sale7.731831,41586,916Dec 20 04:01 PM
Gagnon Robert E.DirectorDec 19Sale7.731301,00546,212Dec 20 04:03 PM
Stuglik Brian MDirectorDec 18Sale7.644873,72190,724Dec 20 04:00 PM
Gagnon Robert E.DirectorDec 18Sale7.642842,17046,342Dec 20 04:03 PM
Paterson DanPresident and CEODec 18Sale7.642441,86487,099Dec 20 04:01 PM
Calkins DanielVice President of FinanceOct 05Sale7.305368,432Oct 10 04:31 PM
Calkins DanielVice President of FinanceSep 25Sale9.40252358,437Sep 25 04:46 PM
Calkins DanielVice President of FinanceSep 21Sale9.312322,1608,462Sep 25 04:46 PM
Stuglik Brian MDirectorSep 19Sale9.842742,69691,211Sep 20 04:15 PM
Paterson DanPresident and CEOSep 19Sale9.841831,80187,343Sep 20 04:15 PM
Gagnon Robert E.DirectorSep 19Sale9.841301,27946,626Sep 20 04:15 PM
Stuglik Brian MDirectorSep 18Sale9.914784,73791,485Sep 20 04:15 PM
Gagnon Robert E.DirectorSep 18Sale9.912782,75546,756Sep 20 04:15 PM
Paterson DanPresident and CEOSep 18Sale9.912402,37887,526Sep 20 04:15 PM
Calkins DanielVice President of FinanceJul 06Sale8.025408,694Jul 10 04:05 PM
Calkins DanielVice President of FinanceJun 26Sale8.17262128,422Jun 28 04:11 PM
Stuglik Brian MChief Executive OfficerJun 20Sale10.302752,83291,963Jun 21 04:23 PM
Paterson DanPresident and COOJun 20Sale10.301831,88537,766Jun 21 04:25 PM
Gagnon Robert E.DirectorJun 20Sale10.301301,33947,034Jun 21 04:24 PM
Stuglik Brian MChief Executive OfficerJun 16Sale9.924874,83192,238Jun 21 04:23 PM
Gagnon Robert E.DirectorJun 16Sale9.922832,80747,164Jun 21 04:24 PM
Paterson DanPresident and COOJun 16Sale9.922442,42037,949Jun 21 04:25 PM
Calkins DanielVice President of FinanceApr 05Sale0.377528101,397Apr 06 04:30 PM
Calkins DanielVice President of FinanceMar 24Sale0.42378159101,472Mar 28 04:30 PM
Stuglik Brian MChief Executive OfficerMar 20Sale0.433,5081,5081,112,736Mar 20 04:54 PM
Paterson DanPresident and COOMar 20Sale0.432,3391,006458,351Mar 20 04:57 PM
Gagnon Robert E.DirectorMar 20Sale0.431,664716569,399Mar 20 04:59 PM
Stuglik Brian MChief Executive OfficerMar 16Sale0.406,2762,5101,116,244Mar 20 04:54 PM
Gagnon Robert E.DirectorMar 16Sale0.403,6541,462571,063Mar 20 04:59 PM
Paterson DanPresident and COOMar 16Sale0.403,1381,255460,690Mar 20 04:57 PM